Answer
Breastfeeding should be avoided during Multaq (dronedarone) treatment and for 7 days (about 5 half-lives) after the final dose, with the decision to stop breastfeeding or discontinue/abstain from therapy weighing breastfeeding benefits for the child against therapy benefits for the woman.
Sources for this answer
- Multaq 400mg tabletsSANOFI · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 18Document updated
Sources checked